It has a couple of GLP-1 products that account for more than half of its top line. Competition in this space has been on the rise, including from top pharma companies. Eli Lilly (NYSE: LLY) is the ...

It has a couple of GLP-1 products that account for more than half of its top line. Competition in this space has been on the rise, including from top pharma companies. Whether it can continue rallying ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of more than $760 billion. It has been soaring in recent years due to the success of its highly ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Fintel reports that on October 8, 2025, Guggenheim maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy recommendation. Analyst Price Forecast Suggests 7.19% Upside As of September 29, 2025, the ...

“It’s being comfortable with being uncomfortable, as my dad has always told me. Pain is a weakness of the mind,” said Charley Hull. This statement of hers aptly suits the kind of player she is.

Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Eli Lilly (LLY) to $1,023 from $1,028 and keeps an Overweight rating on the shares. The firm is adjusting its estimates to ...

MILWAUKEE (AP) — Milwaukee Brewers outfielder Jackson Chourio’s status for Game 2 of the NL Division Series against the Chicago Cubs remained uncertain Sunday, a day after he underwent an MRI on his ...